AMEX · PHGE

BiomX Inc.

$0.20 +$0.01 (+4.44%) 1D Pre-market
Session Pulse Pre-market chatter is louder than usual 1 mentions on Mon No new SEC filings since Mon close its sector ranked 5/11 this week Full pulse →

Key Metrics

$2.14M
Market cap
P/E · TTM
Revenue · TTM
−$11.48M
Net income
EPS · TTM $-0.55
Dividend yield
Free cash flow
Beta · 1Y 0.69
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Offering paper hit the record (Form 424B5).

    424B5 - BiomX Inc. (0001739174) (Filer)

    RECEIPT: SEC FORM 424B5, TIMESTAMPED
  • Jul 24
    From its Mar 10 high, the share price fell 97%.

    Peak close $7.50 on Mar 10; trough close $0.19 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -97%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 26
    The stock moved +98.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 26
  • May 20
    The stock moved +59.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 20

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.04M
Enterprise value
Shares outstanding10.8M
52-wk range$0.18 – $8.50
Avg volume · 20D690.4K
Net cash
Book value / share$-0.04
IndustryBiological Products, (No Diagnostic Substances)
ExchangeAMEX
About BiomX Inc.
IPO dateMar 13, 2019
Employees20

BiomX Inc is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -98.7% · —

Financial Health

Current ratio1.24
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$596.00K

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings